Protective effects of p-coumaric acid against high-fat diet-induced metabolic dysregulation in mice.


Journal

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
ISSN: 1950-6007
Titre abrégé: Biomed Pharmacother
Pays: France
ID NLM: 8213295

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 06 05 2021
revised: 16 07 2021
accepted: 23 07 2021
pubmed: 2 8 2021
medline: 7 1 2022
entrez: 1 8 2021
Statut: ppublish

Résumé

p-Coumaric acid (PC), a naturally occurring phytochemical, possesses antioxidant and anti-inflammatory properties; however, the mechanisms underlying its protective effects against obesity-related metabolic dysfunction are largely unknown. Here, we treated C57BL/6J mice to a high-fat diet (HFD) with or without PC (10 mg/kg body weight/day) for 16 weeks to determine whether PC ameliorates HFD-induced obesity, insulin resistance, inflammation, and non-alcoholic fatty liver disease (NAFLD). We found no significant differences in food intake and body weight between the groups. However, PC-treated mice showed significantly lower white adipose tissue (WAT) weight, adipocyte size, and plasma leptin level, which were associated with decreased lipogenic enzyme activity and mRNA expression of their genes in the epididymal WAT. Moreover, hepatic lipogenic enzymes activities and expression of their genes and proteins were decreased with concomitant increases in hepatic fatty acid oxidation and mRNA expression of its gene; fecal lipid excretion was significantly increased, resulting in decreased liver weight, hepatic lipid levels, lipid droplet accumulation, and plasma aspartate aminotransferase and lipid levels. Additionally, PC-treated mice showed lower fasting blood glucose, plasma resistin, and MCP-1 levels, HOMA-IR, and mRNA expression of inflammatory genes in the epididymal WAT and liver. Our findings reveal potential mechanisms underlying the action of PC against HFD-induced adiposity, NAFLD, and other metabolic disturbances.

Identifiants

pubmed: 34333285
pii: S0753-3322(21)00751-4
doi: 10.1016/j.biopha.2021.111969
pii:
doi:

Substances chimiques

Anti-Inflammatory Agents 0
Antioxidants 0
Blood Glucose 0
Coumaric Acids 0
Resistin 0
p-coumaric acid IBS9D1EU3J

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

111969

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Auteurs

Dae Seong Yoon (DS)

Department of Food Science and Nutrition, Pukyong National University, Busan, Republic of Korea.

Su Yeon Cho (SY)

Department of Food Science and Nutrition, Pukyong National University, Busan, Republic of Korea.

Hye Jin Yoon (HJ)

Department of Food Science and Nutrition, Pukyong National University, Busan, Republic of Korea.

Sang Ryong Kim (SR)

School of Life Sciences, BK21 plus KNU Creative BioResearch Group, Kyungpook National University, Daegu, Republic of Korea; Brain Science and Engineering Institute, Kyungpook National University, Daegu, Republic of Korea.

Un Ju Jung (UJ)

Department of Food Science and Nutrition, Pukyong National University, Busan, Republic of Korea. Electronic address: jungunju@naver.com.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH